Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Mycophenolate mofetil during pregnancy: some words of caution.

Vento M, Perez Aytes A, Ledo A, Boso V, Carey JC.

Pediatrics. 2008 Jul;122(1):184-5. doi: 10.1542/peds.2008-0348. No abstract available.

PMID:
18596003
2.

Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.

Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F.

Obstet Gynecol. 2004 May;103(5 Pt 2):1091-4.

PMID:
15121619
3.

Sonographic diagnosis of fetal malformations associated with mycophenolate mofetil exposure in utero.

Huang SY, Chueh HY, Shaw SW, Shih JC, Cheng PJ.

Am J Obstet Gynecol. 2008 Aug;199(2):e6-8. doi: 10.1016/j.ajog.2008.04.008. Epub 2008 May 19.

PMID:
18486091
4.

The safety of mycophenolate mofetil in pregnancy.

Pisoni CN, D'Cruz DP.

Expert Opin Drug Saf. 2008 May;7(3):219-22. doi: 10.1517/14740338.7.3.219 .

PMID:
18462179
5.
6.

Mycophenolate mofetil for transplantation: new drug, old problems?

Gray DW.

Lancet. 1995 Aug 12;346(8972):390. No abstract available.

PMID:
7623565
7.

Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use.

Tjeertes IF, Bastiaans DE, van Ganzewinkel CJ, Zegers SH.

J Perinatol. 2007 Jan;27(1):62-4.

PMID:
17180133
8.

Even low dose of mycophenolate mofetil in a mother recipient of heart transplant can seriously damage the fetus.

Andrade Vila JH, da Silva JP, Guilhen CJ, Baumgratz JF, da Fonseca L.

Transplantation. 2008 Jul 27;86(2):369-70. doi: 10.1097/TP.0b013e31817cf28a. No abstract available.

PMID:
18645507
9.

Mycophenolate mofetil--a new immunosuppressant for organ transplantation.

[No authors listed]

Med Lett Drugs Ther. 1995 Sep 29;37(958):84-6. No abstract available.

PMID:
7674993
10.

[Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].

Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.

Hautarzt. 2000 Feb;51(2):63-9. Review. German.

PMID:
10743574
11.

Mycophenolate mofetil: emerging as a potential human teratogen.

Koren G.

Can Fam Physician. 2008 Aug;54(8):1112-3.

12.

[Mycophenolate mofetil: a new approach by immunosuppressive treatment].

Thervet E.

Pathol Biol (Paris). 2001 Feb;49(1):9-11. French. No abstract available.

PMID:
11265229
13.

Severe facial clefts in acrofacial dysostosis: a consequence of prenatal exposure to mycophenolate mofetil?

Schoner K, Steinhard J, Figiel J, Rehder H.

Obstet Gynecol. 2008 Feb;111(2 Pt 2):483-6. doi: 10.1097/01.AOG.0000298347.18812.a4. Erratum in: Obstet Gynecol. 2008 Apr;111(4):996.

PMID:
18238994
14.

Mycophenolate mofetil and cough.

Elli A, Aroldi A, Montagnino G, Tarantino A, Ponticelli C.

Transplantation. 1998 Aug 15;66(3):409. No abstract available.

PMID:
9721817
15.

Omission of azathioprine and mycophenolate mofetil in immunosuppressive regimen in kidney transplantation.

Taheri M, Pourmand G, Mehrsai AR, Mansoori D.

Transplant Proc. 2003 Nov;35(7):2752-3. No abstract available.

PMID:
14612105
16.

Hepatitis C and mycophenolate mofetil--a clarification.

Fasola CG, Klintmalm GB.

Liver Transpl. 2002 Apr;8(4):411-2; author reply 412-3. No abstract available.

17.

Mycophenolate mofetil for the transplanted kidney?

[No authors listed]

Drug Ther Bull. 1997 May;35(5):38-40. Review.

PMID:
9282420
18.

Mycophenolate mofetil.

Becker BN.

Transplant Proc. 1999 Nov;31(7):2777-8. Review.

PMID:
10578287
19.

Congenital malformations with low-dose mycophenolate mofetil after kidney transplantation.

Koshy AN, Strong D, Earles G, Fassett RG.

Nephrology (Carlton). 2010 Feb;15(1):133-5. doi: 10.1111/j.1440-1797.2009.01153.x. No abstract available.

PMID:
20377782
20.

[Mycophenolate mofetil in comparison with other immunosuppressive drugs].

Schnülle P, van der Woude FJ.

Internist (Berl). 1998 Aug;39(8):879-86. Review. German. No abstract available.

PMID:
9757398

Supplemental Content

Support Center